Feb 10, 2026 | Benefits Advisory Conference, Benefits management, Cancer, Caroline Fraker, Compliance, Forensic claims review, Gene therapy, GLP-1s, High-cost claims, MedBen University, No Surprises Act (NSA), Obesity, Orphan diseases, Pharmacy, Specialty Drugs, Stop-Loss, Transplants
Consultants and advisors from 10 different states attended the MedBen 2026 Benefits Advisory Conference on January 28. The event featured insights from some of the industry’s most respected voices and gave brokers a clearer view of today’s benefits landscape, what...
Feb 6, 2026 | Cancer, MedBen WellLiving, News, Preventive Care
The fight against cancer has reached a major turning point. According to the American Cancer Society (ACS), seven in 10 people diagnosed with cancer in the U.S. now survive at least five years — a milestone that reflects decades of progress in prevention, detection,...
Sep 23, 2025 | Brian Fargus, Brooke Hupp, Cancer, Conferences, Cost Savings, Drug costs, Health care costs, Innovations, Pharmacy, Prescription, Rx Costs, Savings
The 12th Annual Sherrill-Morgan Healthcare Conference, held September 18-19, convened employers from Ohio, Kentucky, and Tennessee to explore innovative approaches to managing escalating healthcare costs. MedBen was proud to participate, with its sales team delivering...
Sep 19, 2025 | Cancer, MedBen WellLiving, Primary Care, Research, Study, Wellness, Wellness exam, Wellness screenings
New research underscores the importance of having a trusted primary care physician – not only for day-to-day health, but also for long-term care. As cancer treatments advance, more patients are living longer, with 22.5 million survivors projected by 2032. But the...
Aug 22, 2025 | Cancer, Colon Cancer, Colonoscopy, MedBen WellLiving, Preventive Care, Primary Care, Research, Wellness screenings
New research from the American Cancer Society highlights the life-saving and cost-saving value of early colon cancer detection – a priority in MedBen WellLiving’s proactive wellness approach. Screenings for U.S. adults aged 45 to 49 rose 62% from 2019 to 2023,...
Aug 12, 2025 | Cancer, Chronic conditions, Heart disease, MedBen WellLiving, Preventive Care, Stop-Loss, Wellness, Wellness exam, Wellness screenings
In its 2025 High-Cost Claims and Injectable Drug Trend Analysis, Sun Life highlights a familiar but costly trend: malignant neoplasm (cancer) and cardiovascular disease continue to rank among the top drivers of stop-loss claim reimbursements. These chronic conditions...
